Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Warsaw

About this trial

The aim of this observational study is to determine content of rare metals and other elements, along with the levels of selected immunological parameters, in the tissue of the hip or knee joint in the course of degenerative diseases. Determining potential disturbances in the levels or functions of these parameters may in the future contribute to improving treatment - for example, through supplementation of deficient metals or modulation at the immunological level. The main question it aims to answer is:

Are selected rare metals, trace elements and other selected immunological parameters lowered in the tissue of the hip or knee joint as well as in serum in the course of osteoarthritis?

Eligibility criteria

Qualifiers

18 years old and more

patient qualified for primary TKA or primary THA

patient diagnosed with hip or knee osteoarthritis

a complete set of tissues of good quality and volume is available

Disqualifiers

lack of written consent to participate in the study or surgery

any private or professional relationship with the Investigators

genetic connective tissue diseases (e.g., Ehlers-Danlos syndrome and others)

genetic metabolic diseases (e.g., gout and others)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 2 trial groups

Sponsors and collaborators